Moderna Inc (MIL:1MRNA)
€ 38.165 -0.445 (-1.15%) Market Cap: 14.61 Bil Enterprise Value: 9.32 Bil PE Ratio: 0 PB Ratio: 1.30 GF Score: 44/100

Moderna Inc at JPMorgan Healthcare Conference Transcript

Jan 08, 2024 / 11:45PM GMT
Jessica Macomber Fye
JPMorgan Chase & Co, Research Division - Analyst

Great. Welcome, everyone. Good afternoon. Good afternoon. My name is Jess Fye. I'm a biotech analyst at JPMorgan, and we're continuing the 42nd Annual Healthcare Conference today with Moderna.

I'm going to pass it over to the company's CFO, Jamey Mock, for a presentation, and then we're going to go into Q&A. If you have a question, you can submit them to the portal, or I think someone will bring you a mic. But with that, let me pass it over to Jamey.

James M. Mock
Moderna, Inc. - CFO

Terrific. Well, thank you, Jess, and thanks to the JPMorgan team for another terrific conference. Good afternoon, and it's a pleasure to be here with you today. On behalf of the entire global Moderna team, we thank you for your interest. Thank you for being here in person or live via our webcast.

So before I begin, I will make -- in this presentation, we'll make forward-looking statements. Those are to the best of our estimates right now and that's subject to risks and uncertainties.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot